Abdul Hamid Bazarbachi

Columbia University Irving Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Jordi Esteve Reyner

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

SPAIN

View details

Didier Blaise

Professor of Medicine

Aix-Marseille University

FRANCE

View details

Jill Corre

FRANCE

View details

Jesus Gonzalez-Lugo

Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

Giovanni Parmigiani

Professor

Dana-Farber Cancer Institute

UNITED STATES

View details

Divaya Bhutani

Columbia University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Abdul Hamid Bazarbachi

Research Interests

Explore related searches

Contact this professor

Articles (11)

Precision medicine for multiple myeloma: The case for translocation (11;14)

Posttransplant cyclophosphamide versus anti‐thymocyte globulin versus combination for graft‐versus‐host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT

Timing and outcomes of second‐line therapy in the era of daratumumab‐based frontline therapy in AL amyloidosis

Cytokines in hematopoietic cell transplantation and related cellular therapies

Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination.

Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Allogeneic haematopoietic cell transplantation for myelofibrosis: a real‐life perspective

Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies

Collaborators (6)

Jordi Esteve Reyner

Didier Blaise

Jill Corre

Jesus Gonzalez-Lugo

Giovanni Parmigiani

Divaya Bhutani

Make your next move.